-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 WpaYhcnD4zXKBpw7ZwkcGKQcrDXWAK3NqVK3UNAW9g7olHMOC5hu0rPxrzaUOW6l
 Jeuk5fFPID84N0sLLf6IOw==

<SEC-DOCUMENT>9999999997-02-028247.txt : 20020514
<SEC-HEADER>9999999997-02-028247.hdr.sgml : 20020514
<PAPER>
ACCESSION NUMBER:		9999999997-02-028247
CONFORMED SUBMISSION TYPE:	REGDEX
PUBLIC DOCUMENT COUNT:		1
ITEM INFORMATION:		
ITEM INFORMATION:		
FILED AS OF DATE:		20020502

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CUMBERLAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0001087294

	FILING VALUES:
		FORM TYPE:		REGDEX
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	021-43359
		FILM NUMBER:		02032725

	BUSINESS ADDRESS:	
		STREET 1:		209 TENTH AVENUE SOUTH
		STREET 2:		SUITE 332
		CITY:			NASHVILLE,
		STATE:			TN
		ZIP:			37203
</SEC-HEADER>
<DOCUMENT>
<TYPE>REGDEX
<SEQUENCE>1
<FILENAME>9999999997-02-028247.paper
<DESCRIPTION>AUTO-GENERATED PAPER DOCUMENT
<TEXT>
This document was generated as part of a paper submission.
Please reference the Document Control Number 02032725 for access to the original document.
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
